2025’s best-performing Minnesota public company stock is a biopharmaceutical firm with no revenue
- Posted on January 1, 2026
- By Star Tribune
- 2 Views
2025’s best-performing Minnesota public company stock is a biopharmaceutical firm with no revenue
Celcuity, a clinical-stage company developing a cancer drug, had promising clinical trials. Among Minnesota’s public companies, half saw their stock increase this year.
